Scarica l'app Stockscreener
36.64
0.87%
-0.32
Dopo l'orario di chiusura:
36.64
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Gsk Plc Adr Borsa (GSK) Ultime notizie
April 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against GSK - GlobeNewswire Inc.
Deadline Alert: GSK plc. (GSK) Investors Who Lost Money - GlobeNewswire
Deadline Alert: GSK plc. (GSK) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - TradingView
A closer look at Gold Fields Ltd ADR’s (GFI) current quarter earnings projections - US Post News
Law Offices of Frank R. Cruz Encourages GSK plc. (GSK) Investors To Inquire About Securities Fraud Class Action - Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages GSK plc. (GSK) Investors To Inquire About Securities Fraud Class Action - Business Wire
Is GSK Plc ADR (GSK) worth investing in despite its undervalued state? - US Post News
Chewy Inc (CHWY) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News
GSK PLC Stockholder Notice: Shareholder Rights Law Firm - GlobeNewswire
O’Reilly Automotive, Inc [ORLY] stock for 2,179,380 USD was sold by CONN TAMARA F. - Knox Daily
Buying Buzz: GSK Plc ADR [GSK] 10% Owner GSK plc purchases 2,791,930 shares of the company - Knox Daily
Bear Of The Day: GSK PLC (GSK) - Yahoo Finance
MNKD Shares Experience Surge in Value - Knox Daily
Torrid Holdings Inc [CURV] Shares Jump Approximately 29.38% Over the Year - Knox Daily
D-Wave Quantum Inc [QBTS] Records 200-Day SMA of $2.33 - Knox Daily
Rumble Inc [RUM] Records 50-Day SMA of $10.53 - Knox Daily
Investor Alert: Robbins LLP Informs Stockholders of the GSK PLC Class Action - PR Newswire
Rosen Law Firm Urges GSK plc (NYSE: GSK) Investors with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
Wall Street Analyst Downgrade Melco Resorts & Entertainment Ltd ADR [MLCO]. What else is Wall St. saying - The DBT News
GSK Beats on Q4 Earnings & Sales, Stock Up on Raised Long-Term Outlook - Yahoo Finance
For Juniper Networks Inc [JNPR], Analyst sees a rise to $40. What next? - The DBT News
Market Analysts see Apollo Global Management Inc [APO] gaining to $188. Time to buy? - The DBT News
Tuya Inc ADR [TUYA] Revenue clocked in at $280.97 million, up 66.48% YTD: What’s Next? - The DBT News
GSK Plc ADR (GSK) Stock: A Comprehensive 52-Week Review - The InvestChronicle
The Significance of Moving Averages in BridgeBio Pharma Inc Inc. (BBIO) Price Performance - The InvestChronicle
Top investors say GSK Plc ADR (GSK) ticks everything they need - SETE News
GSK share price - GSK
Earnings Preview: GSK (GSK) Q4 Earnings Expected to Decline - Yahoo Finance
Are Investors Keen On Selling Holdings In GSK Plc ADR (NYSE: GSK)? - Stocks Register
Dow Inc (NYSE: DOW) Is A Buzzing Hot Stock - Stocks Register
The 10 Best Companies to Invest in Now - Morningstar
In 2025, GSK Plc ADR (NYSE: GSK) Shares Will Likely Be Bullish - Stocks Register
18 of the Best Stocks and ETFs to Buy Based on 2025 Expert Forecasts - Morningstar
Precidian Investments Builds Out Its ADRhedged ETF Lineup with Four New Strategies, Offering Targeted International Exposure with Integrated Currency Hedge - Business Wire
Gsk Plc ADR (GSK-N) QuotePress Release - The Globe and Mail
Best International Companies to Own: 2025 Edition - Morningstar
FDA Accepts GSK's Filing for Expanded Use of Nucala in COPD - MSN
GSK Stock Declines 20% In 3 Months: Should You Buy, Sell Or Hold? - Barchart
GSK Stock Declines 20% in 3 Months: Should You Buy, Sell or Hold? - Zacks Investment Research
FDA Accepts GSK's Filing For Expanded Use Of Nucala In COPD - Barchart
0.61%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):